A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

June 19, 2025

Study Completion Date

July 17, 2025

Conditions

Healthy

Interventions

DRUG

MK-8527

Oral Tablet

DRUG

CBZ

Oral Extended-release Capsule

Trial Locations (1)

Celerion ( Site 0001), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06893081 - A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012) | Biotech Hunter | Biotech Hunter